Abstract:Yan Song, 1 Wei Wang, 2 Yanqing Xie, 1 Bin Xiang, 1 Xuan Huang, 1 Weijie Guan, 1 Jinping Zheng 1 1 State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, People's Republic of China; 2 Drug Research Institute of Guangzhou BaiYunShan Pharmaceutical General Factory, Guangzhou, 510515, People's Republic of China Correspondence: Jinping Zheng First Affiliated Hospital of Guangzhou Medical University, No 151 Yanjiang Road, Guangzhou 510120, People's Republic of China Tel +86 208 306 2869 Fax +86 208 306 2729 Email jpzhenggy@163.com Background: Cigarette smoke (CS) results in chronic mucus hypersecretion and airway inflammation, contributing to COPD pathogenesis. Mucin 5B (MUC5B) and mucin 5 AC (MUC5AC) are major mucins implicated in COPD pathogenesis. Carbocisteine can reduce mucus viscosity and elasticity. Although carbocisteine decreased human elastase-induced MUC5AC expression in vitro and reduced MUC5AC expression that alleviated bacteria adhesion and improved mucus clearance in vivo, the roles of carbocisteine in inducing MUC5B expression in COPD remain unclear. Methods: To investigate the Muc5b/Muc5ac ratio and the gene and protein levels of Muc5b in COPD and carbocisteine intervention models. C57B6J mice were used to develop COPD model by instilling intratracheally with lipopolysaccharide on days 1 and 14 and were exposed to CS for 2 hr twice a day for 12 weeks. Low and high doses of carbocisteine 112.5 and 225 mg/kg/d, respectively, given by gavage administration were applied for the treatment in COPD models for the same duration, and carboxymethylcellulose was used as control. Carbocisteine significantly attenuated inflammation in bronchoalveolar lavage fluid and pulmonary tissue, improved pulmonary function and protected against emphysema. Results: High-dose carbocisteine significantly decreased the overproduction of Muc5b ( P <0.01) and Muc5ac ( P <0.001), and restored Muc5b/Muc5ac ratio in COPD model group ( P <0.001). Moreover, the Muc5b/Muc5ac ratio negatively correlated with pro-inflammatory cytokines such as IL-6 and keratinocyte-derived cytokine, mean linear intercept, functional residual capacity and airway resistance, but positively correlated with dynamic compliance. Conclusions: These findings suggest that carbocisteine attenuated Muc5b and Muc5ac secretion and restored Muc5b protein levels, which may improve mucus clearance in COPD. Keywords: COPD, cigarette smoke, Muc5b, Muc5ac, carbocisteine

Muscarinic receptor M3 activation promotes fibrocytes contraction

The activation of M3 mAChR in airway epithelial cells promotes IL-8 and TGF-β1 secretion and airway smooth muscle cell migration

Combination of Glycopyrronium and Indacaterol Inhibits Carbachol-Induced ERK5 Signal in Fibrotic Processes.

M3 Subtype of Muscarinic Acetylcholine Receptor Inhibits Cardiac Fibrosis Via Targeting Microrna-29B/beta-site App Cleaving Enzyme 1 Axis.

Regulation of the Muscarinic M3 Receptor by Myocardin-Related Transcription Factors

Effects of M3 muscarinic acetylcholine receptor on alpha smooth muscle-actin expression in cardiac fibroblasts and associated mechanism

Activity of Matrix Metalloproteinase in Airway Epithelial Cells of COPD Patients.

Involvement of Muscarinic M3 Receptor in the Development of M2 Macrophages in Allergic Inflammation

Contractile Properties of Intrapulmonary Airway Smooth Muscle in Cystic Fibrosis

Reducing cholinergic constriction: the major reversible mechanism in COPD

Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells

Machr Activation Induces Epithelial‐mesenchymal Transition on Lung Epithelial Cells (1176.10)

Chronic treatment of β-blocker inhibited mucus hypersecretion and MUC5AC expression exposed to cigarette smoking through β-arrestin2–ERK1/2 pathway

M <sub>3</sub> receptor modulates extracellular matrix synthesis via ERK1/2 signaling pathway in human bladder smooth muscle cells

M3 Machr-Mediated IL-8 Expression Through PKC/NF-κB Signaling Pathways

Effects of (a Combination of) the Beta2-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction

MiR-1307-5p enhances fibroblast transdifferentiation to exacerbate chronic obstructive pulmonary disease through regulating FBXL16/HIF1α axis

MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model

Carbocisteine inhibits the expression of Muc5b in COPD mouse model

M 3 receptor modulates extracellular matrix synthesis via ERK1/2 signaling pathway in human bladder smooth muscle cells.